세이지

Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis.

1. JAMA Psychiatry. 2025 Sep 1;82(9):896-904. doi: 10.1001/jamapsychiatry.2025.1362. Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Kalfas M(1), Tsapekos D(1), Butler M(2), McCutcheon RA(3)(4)(5), Pillinger T(5)(6), Strawbridge R(1), Bhat

Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis.

2. Psychiatry Res. 2024 Oct;340:116124. doi: 10.1016/j.psychres.2024.116124. Epub 2024 Aug 9. Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis. Vita G(1), Pollini D(1), Canozz

Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis "Nutra NMA SCZ".

3. Mol Psychiatry. 2025 Jan;30(1):168-187. doi: 10.1038/s41380-024-02645-y. Epub 2024 Jul 18. Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis "Nutra NMA SCZ". Fornaro M(#)(1), Caiazza C(#)(2), Billeci M(2), Berk M(3)(4)(5)(6)(7),

Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis.

4. Mol Psychiatry. 2022 Sep;27(9):3658-3669. doi: 10.1038/s41380-022-01652-1. Epub 2022 Jun 27. Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis. Medeiros GC(1)(2), Gould TD(2)(3)(4), Prueitt WL(5), Nanavati J(6), Grunebaum MF(7

Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.

5. Mol Autism. 2022 Mar 4;13(1):10. doi: 10.1186/s13229-022-00488-4. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Siafis S(1), Çıray O(2), Wu H(3), Schneider-Thoma J(3), Bighelli I(3), Krause M(4), Rodolico A(5), C

Association between food insecurity and depression among older adults from low- and middle-income countries.

6. Depress Anxiety. 2021 Apr;38(4):439-446. doi: 10.1002/da.23147. Epub 2021 Mar 9. Association between food insecurity and depression among older adults from low- and middle-income countries. Smith L(1), Il Shin J(2), McDermott D(3), Jacob L(4)(5), Barnett Y(6), López-Sánchez GF(7), Veronese N(

Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis.

7. Mol Autism. 2020 Aug 26;11(1):66. doi: 10.1186/s13229-020-00372-z. Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis. Siafis S(1), Çıray O(2), Schneider-Thoma J(3), Bighelli I(3), Krause M(3), Ro

Patient and provider perspectives of Brief Cognitive Behavioral Therapy for Chronic Pain: a qualitative analysis of a pilot randomized controlled trial.

8. Transl Behav Med. 2026 Jan 7;16(1):ibag011. doi: 10.1093/tbm/ibag011. Patient and provider perspectives of Brief Cognitive Behavioral Therapy for Chronic Pain: a qualitative analysis of a pilot randomized controlled trial. Conrad M(1)(2), Kimber JM(3)(4), Moskal D(5), Pietropaoli VA, King PR J

Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial.

9. Front Immunol. 2026 Mar 23;17:1789248. doi: 10.3389/fimmu.2026.1789248. eCollection 2026. Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial. Batmunkh T(1), Neal EF(2)(3), Amraa O(1), Mazarakis N(2)(3), Altangerel B(4

Personalized fMRI-Guided TMS Targeting the Threat Neurocircuitry in PTSD: A Randomized Clinical Trial.

10. Am J Psychiatry. 2026 May 1;183(5):343-354. doi: 10.1176/appi.ajp.20250749. Epub 2026 Apr 2. Personalized fMRI-Guided TMS Targeting the Threat Neurocircuitry in PTSD: A Randomized Clinical Trial. van Rooij SJH(1), Langhinrichsen-Rohling R(1), Minton ST(1), Hinojosa CA(1)(2), Lukemire J(3),

The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.

11. J Affect Disord. 2026 Aug 1;406:121662. doi: 10.1016/j.jad.2026.121662. Epub 2026 Mar 23. The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis. Goodwin GM(1), Aaronson ST(2), Alvarez O(3), Carhart-Harris R(4), Croal M(5), Feif

Efficacy and safety of brexpiprazole in early-episode schizophrenia: post hoc analysis of Phase 3 clinical trials in adults and adolescents.

12. Psychiatry Res. 2026 Jun;360:117091. doi: 10.1016/j.psychres.2026.117091. Epub 2026 Mar 12. Efficacy and safety of brexpiprazole in early-episode schizophrenia: post hoc analysis of Phase 3 clinical trials in adults and adolescents. Correll CU(1), Yildirim M(2), Zhang Z(3), Palma AM(3), Pham

Transient frontal spectral events from EEG predict antidepressant response to sertraline in depression.

13. J Psychiatr Res. 2026 Jun;197:313-320. doi: 10.1016/j.jpsychires.2026.03.010. Epub 2026 Mar 11. Transient frontal spectral events from EEG predict antidepressant response to sertraline in depression. Waller DA(1), Carpenter LL(2), Jones SR(3). Author information: (1)Department of Neuroscien

A Randomized Trial of Vitamin D Supplementation and COVID-19 Clinical Outcomes and Long COVID: The Vitamin D for COVID-19 Trial.

14. J Nutr. 2026 Apr;156(4):101398. doi: 10.1016/j.tjnut.2026.101398. Epub 2026 Mar 12. A Randomized Trial of Vitamin D Supplementation and COVID-19 Clinical Outcomes and Long COVID: The Vitamin D for COVID-19 Trial. Ganmaa D(1), Cook KA(2), Khudyakov P(3), Enkhjargal D(4), Bilegtsaikhan T(5),

Assessing the presence of biasing and non-biasing unblinding in a randomized controlled trial of a home-use tDCS device: An exploratory analysis.

15. J Affect Disord. 2026 Jul 15;405:121553. doi: 10.1016/j.jad.2026.121553. Epub 2026 Mar 6. Assessing the presence of biasing and non-biasing unblinding in a randomized controlled trial of a home-use tDCS device: An exploratory analysis. Hieronymus F(1), Huneke NTM(2), Månsson D(3), Rehn EM(3)

Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study.

3. Int J Neuropsychopharmacol. 2026 Apr 6;29(4):pyag009. doi: 10.1093/ijnp/pyag009. Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, explorator

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.

28. Mult Scler. 2026 Apr;32(4):396-408. doi: 10.1177/13524585261425076. Epub 2026 Mar 4. Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial. Bennett JL(1), Bhattacharyya S(2), Zabeti A(3), Levy M(2), de Sèz

Graph neural network-based drug-drug interaction prediction.

5. Sci Rep. 2025 Aug 19;15(1):30340. doi: 10.1038/s41598-025-12936-1. Graph neural network-based drug-drug interaction prediction. Abbas K(1), Hao C(2), Yong X(3), Hasan MK(4), Islam S(5), Rahman AHA(6). Author information: (1)School of Computer Science and Technology, Zhoukou Normal University,

Biased agonism in psychopharmacology: an opportunity to improve efficacy and safety of treatments.

49. CNS Spectr. 2025 Aug 12;30(1):e63. doi: 10.1017/S109285292510045X. Biased agonism in psychopharmacology: an opportunity to improve efficacy and safety of treatments. Le GH(1)(2)(3), Wong S(1)(2)(4), Bargiota S(5), Jennifer S(6)(7), Lo HKY(8), Orsini D(1)(4), Teopiz K(1)(2)(3), Guillen-Burgos

Enhancing antioxidant and antibacterial activities of Cuminum cyminum, Origanum vulgare, and Salvia officinalis essential oils through a synergistic perspective.

32. Sci Rep. 2025 Jul 23;15(1):26728. doi: 10.1038/s41598-025-10814-4. Enhancing antioxidant and antibacterial activities of Cuminum cyminum, Origanum vulgare, and Salvia officinalis essential oils through a synergistic perspective. Gheisary B(1), Ashrafi-Saeidlou S(2), Hassani A(1), Fattahi M(3

Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial.

11. J Psychopharmacol. 2024 Dec;38(12):1122-1136. doi: 10.1177/02698811241282777. Epub 2024 Oct 11. Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial. Dunbar J(1), Walling DP(2), Hassman HA(3), Jain

Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis.

34. Clin Transl Sci. 2024 Jan;17(1):e13682. doi: 10.1111/cts.13682. Epub 2023 Dec 19. Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. Mohamed MF(1), Qian Y(1), D'Cunha R(1), Sligh T(2), Ferris LK(3), El

SSRIs differentially modulate the effects of pro-inflammatory stimulation on hippocampal plasticity and memory via sigma 1 receptors and neurosteroids.

39. Transl Psychiatry. 2023 Feb 3;13(1):39. doi: 10.1038/s41398-023-02343-3. SSRIs differentially modulate the effects of pro-inflammatory stimulation on hippocampal plasticity and memory via sigma 1 receptors and neurosteroids. Izumi Y(1)(2), Reiersen AM(1)(2), Lenze EJ(1)(2), Mennerick SJ(1)(2)

Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.

20. JAMA. 2022 Jul 12;328(2):151-161. doi: 10.1001/jama.2022.9805. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. Oslin DW(1)(2), Lynch KG(1)(2), Shih MC(3)(4),

Assessment of the latest prescribed drug-related problems.

29. Eur Rev Med Pharmacol Sci. 2022 Apr;26(7):2373-2387. doi: 10.26355/eurrev_202204_28467. Assessment of the latest prescribed drug-related problems. Maslub MG(1), Radwan MA, Mikhail MS, Abdalla ZA, Youssef YL, Abdal Hafiz AI, Zain Eldien KM, Sha'aban A. Author information: (1)Pharmacy Practic

Oxysterols Modulate the Acute Effects of Ethanol on Hippocampal N-Methyl-d-Aspartate Receptors, Long-Term Potentiation, and Learning.

16. J Pharmacol Exp Ther. 2021 Apr;377(1):181-188. doi: 10.1124/jpet.120.000376. Epub 2021 Jan 13. Oxysterols Modulate the Acute Effects of Ethanol on Hippocampal N-Methyl-d-Aspartate Receptors, Long-Term Potentiation, and Learning. Izumi Y(1), Mennerick SJ(1), Doherty JJ(1), Zorumski CF(2). Au

Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA(A) receptor positive allosteric modulator.

27. Neuropharmacology. 2020 Dec 15;181:108333. doi: 10.1016/j.neuropharm.2020.108333. Epub 2020 Sep 22. Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA(A) receptor positive allosteric modulator. Althaus AL(1), Ackley MA(2), Belfort GM(2), Gee SM(2), Da

Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials.

21. Lancet Psychiatry. 2025 Dec;12(12):906-920. doi: 10.1016/S2215-0366(25)00296-2. Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials. Keefe RSE(1), Harvey PD(2), Correll CU(3), Fal

Hesitancy and confidence in pediatric COVID-19 vaccination among diverse caregivers of unvaccinated children.

33. Vaccine. 2025 Aug 13;61:127245. doi: 10.1016/j.vaccine.2025.127245. Epub 2025 Jun 4. Hesitancy and confidence in pediatric COVID-19 vaccination among diverse caregivers of unvaccinated children. Costello LM(1), Kerns EK(2), McCulloh RJ(2), Roberts JR(3), Blatt DB(4), Tanski SE(5), Smith TR(

Evidence-based guidelines for the pharmacological treatment of migraine, summary version.

22. Cephalalgia. 2025 Apr;45(4):3331024251321500. doi: 10.1177/03331024251321500. Epub 2025 Apr 25. Evidence-based guidelines for the pharmacological treatment of migraine, summary version. Ornello R(1), Caponnetto V(2), Ahmed F(3), Al-Khazali HM(4), Ambrosini A(5), Ashina S(6)(7), Baraldi C(8)